We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Agilent Technologies and Chungnam National University Collaborate to Further Glycomics Research

News   Aug 26, 2011

 
Agilent Technologies and Chungnam National University Collaborate to Further Glycomics Research
 
 
 

RELATED ARTICLES

Biomarker Identified for Early Beta Cell Death in Type 1 Diabetes

News

Anath Shalev, M.D., and colleagues at the University of Alabama at Birmingham have identified an early biomarker of Type 1 diabetes-associated beta-cell loss in humans — miR-204. “Serum miR-204,” Shalev said, “may provide a much needed novel approach to assess early Type 1 diabetes-associated human beta-cell loss, even before onset of overt disease.”

READ MORE

Novel Drug Candidate Designed, Synthesized and Validated in 46 Days Using AI

News

A team of researchers has successfully used Artificial Intelligence to design, synthesize and validate a novel drug candidate in just 46 days, compared to the typical 2-3 years required using the standard hit to lead approach.

READ MORE

New Biomarker Discovered for Myasthenia Gravis

News

University of Alberta researchers identified a unique biological marker that can be used to identify the presence of the rare autoimmune disease myasthenia gravis, predict the course of the disease and identify new, personalized treatments.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE